Literature DB >> 21224074

Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer.

Baek Gil Kim1, Hee Jung An, Suki Kang, Yoon Pyo Choi, Ming-Qing Gao, Haengran Park, Nam Hoon Cho.   

Abstract

Dense fibrosis, which is caused by desmoplastic reaction, is usually found in invasive ductal carcinoma and may represent the alteration of the tumor microenvironment preceding tumor invasion. Thus, the dense fibrotic zone around invasive ductal carcinoma can be considered to be the actual tissue site of tumor microenvironment, where the precedent alterations for tumor invasion occur. To characterize the dense fibrotic zone, we classified invasive ductal carcinoma tissue into a tumor zone, a normal zone, and the novel interface zone (IZ), which shows dense fibrosis. The postulated IZ is a 5-mm-wide belt that circles the tumor margin and overlaps with normal tissue. Of the extracellular matrix components, laminin-332 was specifically overexpressed in the IZ. Events that appear to be similar to the epithelial-mesenchymal transition, a novel source of myofibroblast formation from epithelial cells, were observed in the IZ, according to the following characteristics: overexpression of matrix metalloproteinase 3, membrane type 1-matrix metalloproteinase, snail, and zinc finger E-box-binding homeobox 1, and the gain of N-cadherin expression, as well as the down-regulation of miR200c. The myofibroblasts isolated from the IZ, which were designated interface zone-fibroblast, displayed laminin-332 and membrane type 1-matrix metalloproteinase overexpression, in contrast with both cancer-associated fibroblasts and normal breast fibroblasts. Taken together, our results suggest that the IZ, which shows dense fibrosis, may provide a specialized microenvironment for guiding tumor invasion: the fibrosis caused by laminin-332 overexpressing myofibroblast formation (interface zone-fibroblast) via epithelial-mesenchymal transition. Copyright Â
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21224074      PMCID: PMC3069863          DOI: 10.1016/j.ajpath.2010.11.028

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors.

Authors:  H Mizushima; Y Miyagi; Y Kikkawa; N Yamanaka; H Yasumitsu; K Misugi; K Miyazaki
Journal:  J Biochem       Date:  1996-12       Impact factor: 3.387

2.  Investigation into the mechanism of the loss of laminin 5 (alpha3beta3gamma2) expression in prostate cancer.

Authors:  J Hao; L Jackson; R Calaluce; K McDaniel; B L Dalkin; R B Nagle
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis.

Authors:  Sarah N Flier; Harikrishna Tanjore; Efi G Kokkotou; Hikaru Sugimoto; Michael Zeisberg; Raghu Kalluri
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

Review 4.  The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay.

Authors:  V M Weaver; A H Fischer; O W Peterson; M J Bissell
Journal:  Biochem Cell Biol       Date:  1996       Impact factor: 3.626

Review 5.  Putting tumours in context.

Authors:  M J Bissell; D Radisky
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

6.  Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.

Authors:  Hidayatullah G Munshi; Yi I Wu; Subhendu Mukhopadhyay; Adam J Ottaviano; Antonella Sassano; Jennifer E Koblinski; Leonidas C Platanias; M Sharon Stack
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

7.  Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma.

Authors:  Gianluigi Giannelli; Emilia Fransvea; Carlo Bergamini; Felice Marinosci; Salvatore Antonaci
Journal:  Clin Cancer Res       Date:  2003-09-01       Impact factor: 12.531

Review 8.  Epithelial-mesenchymal transition and its implications for fibrosis.

Authors:  Raghu Kalluri; Eric G Neilson
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 9.  Integrin signalling during tumour progression.

Authors:  Wenjun Guo; Filippo G Giancotti
Journal:  Nat Rev Mol Cell Biol       Date:  2004-10       Impact factor: 94.444

10.  Identification and characterization of a fibroblast marker: FSP1.

Authors:  F Strutz; H Okada; C W Lo; T Danoff; R L Carone; J E Tomaszewski; E G Neilson
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

View more
  25 in total

1.  Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI.

Authors:  Jeon-Hor Chen; Hon Yu; Muqing Lin; Rita S Mehta; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2013-08-29       Impact factor: 2.546

2.  Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.

Authors:  Katherine N Gibson-Corley; Mary E Herndon; Bo Zhou; Yihan Sun; Elisabeth Gustafson-Wagner; Melissa Teoh-Fitzgerald; Frederick E Domann; Michael D Henry; Christopher S Stipp
Journal:  Mol Cancer Res       Date:  2013-09-03       Impact factor: 5.852

3.  Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.

Authors:  Michael J V White; David Roife; Richard H Gomer
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

4.  Host matrix modulation by tumor exosomes promotes motility and invasiveness.

Authors:  Wei Mu; Sanyukta Rana; Margot Zöller
Journal:  Neoplasia       Date:  2013-08       Impact factor: 5.715

5.  Laminin 332 expression and prognosis in breast cancer.

Authors:  Philip M Carpenter; Argyrios Ziogas; Emma M Markham; Alegria S Cantillep; Rui Yan; Hoda Anton-Culver
Journal:  Hum Pathol       Date:  2018-08-17       Impact factor: 3.466

6.  ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.

Authors:  Camilla Fröhlich; Camilla Nehammer; Reidar Albrechtsen; Pauliina Kronqvist; Marie Kveiborg; Atsuko Sehara-Fujisawa; Arthur M Mercurio; Ulla M Wewer
Journal:  Mol Cancer Res       Date:  2011-08-29       Impact factor: 5.852

Review 7.  In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids.

Authors:  Mahesh Devarasetty; Steven D Forsythe; Ethan Shelkey; Shay Soker
Journal:  Tissue Eng Regen Med       Date:  2020-05-12       Impact factor: 4.169

8.  Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling.

Authors:  Baek Gil Kim; Ming-Qing Gao; Yoon Pyo Choi; Suki Kang; Haeng Ran Park; Kyu Sub Kang; Nam Hoon Cho
Journal:  Breast Cancer Res       Date:  2012-06-06       Impact factor: 6.466

Review 9.  Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.

Authors:  Veronica Romano; Immacolata Belviso; Alessandro Venuta; Maria Rosaria Ruocco; Stefania Masone; Federica Aliotta; Giuseppe Fiume; Stefania Montagnani; Angelica Avagliano; Alessandro Arcucci
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

Review 10.  Laminin-511: a multi-functional adhesion protein regulating cell migration, tumor invasion and metastasis.

Authors:  Normand Pouliot; Nicole Kusuma
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.